Not applicableEnded earlyNCT00393224
What this trial is testing
Defining the Clinical Utility of EBV Antibody Screening to Identify Individuals Susceptible to Nasopharyngeal Carcinoma (NPC) Within High-Risk, Multiplex NPC Families
Who this might be right for
Nasopharyngeal Neoplasms
National Cancer Institute (NCI) 952